Literature DB >> 10202626

The idiopathic nephrotic syndrome.

R W Chesney1.   

Abstract

The nephrotic syndrome is defined by edema, hypoalbuminemia, proteinuria, and hyperlipemia with elevated cholesterol and triglyceride concentrations in serum or plasma. It may be primary or secondary to systemic disorders. Because of its incidence--between 2.0 and 7.0 cases per 100,000 children per year--this disorder is not uncommon in a busy pediatric practice, and it forms the basis of the referrals evaluated by a pediatric nephrology service. Over the 2 years since this subject was reviewed, several articles have appeared that have provided insights into the clinical features, etiology, pathology, pathogenesis, complications, and therapy of the idiopathic primary nephrotic syndrome. Nevertheless, a remarkable feature of this condition remains that the fundamental cause and pathogenesis of the most common form of primary nephrotic syndrome, minimal lesion nephrotic syndrome of childhood, is largely unknown. Hence, a huge challenge remains for researchers in the area of pediatric nephrology.

Entities:  

Mesh:

Year:  1999        PMID: 10202626     DOI: 10.1097/00008480-199904000-00010

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  9 in total

1.  Risk Factors for Steroid Dependency in Children with Idiopathic Nephrotic Syndrome in India.

Authors:  Lesa Dawman; Amarjeet Mehta; Indar Kumar Sharawat; Rajeev Yadav
Journal:  Indian J Pediatr       Date:  2015-07-03       Impact factor: 1.967

2.  Tissue factor pathway inhibitor in childhood nephrotic syndrome.

Authors:  Mohamed M Al-Mugeiren; Abdel Galil M Abdel Gader; Saud A Al-Rasheed; Abdullah A Al-Salloum
Journal:  Pediatr Nephrol       Date:  2006-03-31       Impact factor: 3.714

3.  Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.

Authors:  Alanoud Alshami; Abishek Roshan; Marisa Catapang; Jasper J Jöbsis; Trevor Kwok; Nonnie Polderman; Jennifer Sibley; Matt Sibley; Cherry Mammen; Douglas G Matsell
Journal:  Pediatr Nephrol       Date:  2017-05-24       Impact factor: 3.714

4.  The incidence of the nephrotic syndrome in childhood in Germany.

Authors:  Ingo Franke; Malik Aydin; Corinna Elke Llamas Lopez; Lisa Kurylowicz; Rainer Ganschow; Michael Lentze; Mark Born
Journal:  Clin Exp Nephrol       Date:  2017-06-22       Impact factor: 2.801

5.  Study on Steroid Induced Ocular Findings in Children with Nephrotic Syndrome.

Authors:  Vijay Agrawal; Kusum Devpura; Laxmikant Mishra; Sajan Agarwal
Journal:  J Clin Diagn Res       Date:  2017-03-01

6.  Expression of nephrin in acquired forms of nephrotic syndrome in childhood.

Authors:  Sangeeta R Hingorani; Laura S Finn; Jolanta Kowalewska; Ruth A McDonald; Allison A Eddy
Journal:  Pediatr Nephrol       Date:  2004-01-28       Impact factor: 3.714

Review 7.  Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literature.

Authors:  Loubna El Bakkali; Robert Rodrigues Pereira; Dirk J Kuik; Johannes C F Ket; Joanna A E van Wijk
Journal:  Pediatr Nephrol       Date:  2011-05-01       Impact factor: 3.714

8.  Mycophenolate mofetil (MMF) treatment efficacy in children with primary and secondary glomerulonephritis.

Authors:  Danuta Ostalska-Nowicka; Agnieszka Malinska; Magdalena Silska; Bartlomiej Perek; Jacek Zachwieja; Michal Nowicki
Journal:  Arch Med Sci       Date:  2011-12-30       Impact factor: 3.318

9.  Clinical course & management of childhood nephrotic syndrome in Germany: a large epidemiological ESPED study.

Authors:  Ingo Franke; Malik Aydin; Lisa Kurylowicz; Corinna Elke Llamas Lopez; Rainer Ganschow; Michael J Lentze; Mark Born
Journal:  BMC Nephrol       Date:  2019-02-07       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.